Severe combined immunodeficiency (SCID) with natural killer (NK) cell predominance
Buckley, R.H.; Gard, S.; Haynes, B.F.; Sindel, L.J.; Davis, K.; Sampson, H.A.; Ruff, M.E.; Koren, H.S.
Birth Defects Original Article Series 19(3): 101-104
1983
ISSN/ISBN: 0547-6844 PMID: 6360230 Document Number: 210664
Document emailed within 1 workday
Related Documents
Inada, M.; Yamashita, J.; Ogawa, M. 1997: Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice Research Communications in Molecular Pathology and Pharmacology 97(2): 229-232Sirianni, M.C.; Businco, L.; Fiore, L.; Seminara, R.; Aiuti, F. 1983: T-cell subsets and natural killer cells in DiGeorge and SCID patients Birth Defects Original Article Series 19(3): 107-108
Jansen, B.; Schlagbauer-Wadl, H.; Eichler, H.G.; Wolff, K.; van Elsas, A.; Schrier, P.I.; Pehamberger, H. 1997: Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis Cancer Research 57(3): 362-365
Nokihara, H.; Yanagawa, H.; Nishioka, Y.; Yano, S.; Mukaida, N.; Matsushima, K.; Sone, S. 2000: Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice Cancer Research 60(24): 7002-7007
Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M. 1991: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells Journal of Immunology 146(9): 3074-3081
Lederman, M.M.; Ratnoff, O.D.; Schacter, B.; Shoger, T. 1985: Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines Journal of Laboratory and Clinical Medicine 106(2): 197-204
Rook, A.H.; Hooks, J.J.; Quinnan, G.V.; Lane, H.C.; Manischewitz, J.F.; Macher, A.M.; Masur, H.; Fauci, A.S.; Djeu, J.Y. 1985: Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism Journal of Immunology 134(3): 1503-1507
Hayakawa, K.; Salmeron, M.A.; Kornbluth, J.; Bucana, C.; Itoh, K. 1991: The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone Journal of Immunology 146(7): 2453-2460
Dosch, H.M.; Lee, J.W.; Gelfand, E.W.; Falk, J.A. 1978: Severe combined immunodeficiency disease: a model of T-cell dysfunction Clinical and Experimental Immunology 34(2): 260-267
Shirakawa, F.; Tanaka, Y.; Eto, S.; Suzuki, H.; Yodoi, J.; Yamashita, U. 1986: Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells) Journal of Immunology 137(2): 551-556
Rachelefsky, G.S.; Stiehm, E.R.; Ammann, A.J.; Cederbaum, S.D.; Opelz, G.; Terasaki, P.I. 1975: T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency Pediatrics 55(1): 114-118
Jorgensen, C.; Couret, I.; Canovas, F.; Bologna, C.; Brochier, J.; Reme, T.; Lipsky, P.; Sany, J. 1996: Mononuclear cell retention in rheumatoid synovial tissue engrafted in severe combined immunodeficient (SCID) mice is up-regulated by tumour necrosis factor-alpha (TNF-alpha) and mediated through intercellular adhesion molecule-1 (ICAM-1) Clinical and Experimental Immunology 106(1): 20-25
Schlesinger, M.; Handzel, Z.T.; Reichman, B.; Levin, S. 1978: Severe combined immune deficiency (SCID), variable type, in two sisters Harefuah 94(7-8): 221-223
Hayward, A.R.; Murphy, S.; Githens, J.; Troup, G.; Ambruso, D. 1982: Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency Journal of Pediatrics 100(4): 665-668
Pollack, M.S.; Kapoor, N.; Sorell, M.; Morishima, Y.; Dupont, B.; O'Reilly, R.J. 1981: Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells Transplantation Proceedings 13(1 Part 1): 270-272
Magnuson, N.S.; Perryman, L.E.; Wyatt, C.R.; Ishizaka, T.; Mason, P.H.; Namen, A.E.; Banks, K.L.; Magnuson, J.A. 1984: Continuous cultivation of equine lymphocytes: evidence for occasional T cell-like maturation events in horses with hereditary severe combined immunodeficiency Journal of Immunology 133(5): 2518-2524
Rosenkrantz, K.; Keever, C.; Bhimani, K.; Horvath, A.; Brochstein, J.; O'Reilly, R.; Dupont, B.; Flomenberg, N. 1990: Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency Journal of Immunology 144(5): 1721-1728
Descamps, V.; Blanchet-Bardon, C.; Petit, A.; Baccard, M.; Fisher, A.; Dubertret, L. 1991: Epidermodysplasia verruciformis (EV) after bone marrow transplantation for the treatment of severe combined immunodeficiency: a model to understand the specific immunodeficiency of EV? Annales de Dermatologie et de Venereologie 118(11): 847-850
Djeu, J.Y. 1982: Antibody-dependent cell-mediated cytotoxicity and natural killer-cell phenomenon Journal of the American Veterinary Medical Association 181(10): 1043-1048
Nowak, J.E.; Gomez-Flores, R.; Calderon, S.N.; Rice, K.C.; Weber, R.J. 1998: Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80 Journal of Pharmacology and Experimental Therapeutics 286(2): 931-937